IBDEI331 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49218,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49218,1,3,0)
;;=3^Secondary Malig Neop Cerebral Meninges
;;^UTILITY(U,$J,358.3,49218,1,4,0)
;;=4^C79.32
;;^UTILITY(U,$J,358.3,49218,2)
;;=^5001348
;;^UTILITY(U,$J,358.3,49219,0)
;;=G89.3^^187^2437^30
;;^UTILITY(U,$J,358.3,49219,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49219,1,3,0)
;;=3^Neoplasm Related Pain
;;^UTILITY(U,$J,358.3,49219,1,4,0)
;;=4^G89.3
;;^UTILITY(U,$J,358.3,49219,2)
;;=^5004159
;;^UTILITY(U,$J,358.3,49220,0)
;;=C79.82^^187^2437^36
;;^UTILITY(U,$J,358.3,49220,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49220,1,3,0)
;;=3^Secondary Malig Neop Genital Organs
;;^UTILITY(U,$J,358.3,49220,1,4,0)
;;=4^C79.82
;;^UTILITY(U,$J,358.3,49220,2)
;;=^267339
;;^UTILITY(U,$J,358.3,49221,0)
;;=C49.A2^^187^2437^1
;;^UTILITY(U,$J,358.3,49221,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49221,1,3,0)
;;=3^GIST,Stomach
;;^UTILITY(U,$J,358.3,49221,1,4,0)
;;=4^C49.A2
;;^UTILITY(U,$J,358.3,49221,2)
;;=^8148063
;;^UTILITY(U,$J,358.3,49222,0)
;;=I50.9^^187^2438^16
;;^UTILITY(U,$J,358.3,49222,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49222,1,3,0)
;;=3^Heart Failure,Unsp
;;^UTILITY(U,$J,358.3,49222,1,4,0)
;;=4^I50.9
;;^UTILITY(U,$J,358.3,49222,2)
;;=^5007251
;;^UTILITY(U,$J,358.3,49223,0)
;;=I73.9^^187^2438^22
;;^UTILITY(U,$J,358.3,49223,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49223,1,3,0)
;;=3^Peripheral Vascular Disease,Unspec
;;^UTILITY(U,$J,358.3,49223,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,49223,2)
;;=^184182
;;^UTILITY(U,$J,358.3,49224,0)
;;=I35.0^^187^2438^20
;;^UTILITY(U,$J,358.3,49224,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49224,1,3,0)
;;=3^Nonrheumatic Aortic Vlve Stenosis
;;^UTILITY(U,$J,358.3,49224,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,49224,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,49225,0)
;;=I35.1^^187^2438^19
;;^UTILITY(U,$J,358.3,49225,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49225,1,3,0)
;;=3^Nonrheumatic Aortic Vlve Insuff
;;^UTILITY(U,$J,358.3,49225,1,4,0)
;;=4^I35.1
;;^UTILITY(U,$J,358.3,49225,2)
;;=^5007175
;;^UTILITY(U,$J,358.3,49226,0)
;;=I35.2^^187^2438^21
;;^UTILITY(U,$J,358.3,49226,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49226,1,3,0)
;;=3^Nonrheumatic Aortic Vlve Stenosis w/ Insuff
;;^UTILITY(U,$J,358.3,49226,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,49226,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,49227,0)
;;=I35.9^^187^2438^18
;;^UTILITY(U,$J,358.3,49227,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49227,1,3,0)
;;=3^Nonrheumatic Aortic Vlve D/O,Unsp
;;^UTILITY(U,$J,358.3,49227,1,4,0)
;;=4^I35.9
;;^UTILITY(U,$J,358.3,49227,2)
;;=^5007178
;;^UTILITY(U,$J,358.3,49228,0)
;;=I42.7^^187^2438^3
;;^UTILITY(U,$J,358.3,49228,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49228,1,3,0)
;;=3^Cardiomyopathy d/t Drug/Extrn Agent
;;^UTILITY(U,$J,358.3,49228,1,4,0)
;;=4^I42.7
;;^UTILITY(U,$J,358.3,49228,2)
;;=^5007198
;;^UTILITY(U,$J,358.3,49229,0)
;;=I21.3^^187^2438^23
;;^UTILITY(U,$J,358.3,49229,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49229,1,3,0)
;;=3^STEMI,Unspec Site
;;^UTILITY(U,$J,358.3,49229,1,4,0)
;;=4^I21.3
;;^UTILITY(U,$J,358.3,49229,2)
;;=^5007087
;;^UTILITY(U,$J,358.3,49230,0)
;;=I25.5^^187^2438^17
;;^UTILITY(U,$J,358.3,49230,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49230,1,3,0)
;;=3^Ischemic Cardiomyopathy
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI331 3765 printed Nov 22, 2024@17:50:58 Page 2
IBDEI331 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49218,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,49218,1,3,0)
+4 ;;=3^Secondary Malig Neop Cerebral Meninges
+5 ;;^UTILITY(U,$J,358.3,49218,1,4,0)
+6 ;;=4^C79.32
+7 ;;^UTILITY(U,$J,358.3,49218,2)
+8 ;;=^5001348
+9 ;;^UTILITY(U,$J,358.3,49219,0)
+10 ;;=G89.3^^187^2437^30
+11 ;;^UTILITY(U,$J,358.3,49219,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,49219,1,3,0)
+14 ;;=3^Neoplasm Related Pain
+15 ;;^UTILITY(U,$J,358.3,49219,1,4,0)
+16 ;;=4^G89.3
+17 ;;^UTILITY(U,$J,358.3,49219,2)
+18 ;;=^5004159
+19 ;;^UTILITY(U,$J,358.3,49220,0)
+20 ;;=C79.82^^187^2437^36
+21 ;;^UTILITY(U,$J,358.3,49220,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,49220,1,3,0)
+24 ;;=3^Secondary Malig Neop Genital Organs
+25 ;;^UTILITY(U,$J,358.3,49220,1,4,0)
+26 ;;=4^C79.82
+27 ;;^UTILITY(U,$J,358.3,49220,2)
+28 ;;=^267339
+29 ;;^UTILITY(U,$J,358.3,49221,0)
+30 ;;=C49.A2^^187^2437^1
+31 ;;^UTILITY(U,$J,358.3,49221,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,49221,1,3,0)
+34 ;;=3^GIST,Stomach
+35 ;;^UTILITY(U,$J,358.3,49221,1,4,0)
+36 ;;=4^C49.A2
+37 ;;^UTILITY(U,$J,358.3,49221,2)
+38 ;;=^8148063
+39 ;;^UTILITY(U,$J,358.3,49222,0)
+40 ;;=I50.9^^187^2438^16
+41 ;;^UTILITY(U,$J,358.3,49222,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,49222,1,3,0)
+44 ;;=3^Heart Failure,Unsp
+45 ;;^UTILITY(U,$J,358.3,49222,1,4,0)
+46 ;;=4^I50.9
+47 ;;^UTILITY(U,$J,358.3,49222,2)
+48 ;;=^5007251
+49 ;;^UTILITY(U,$J,358.3,49223,0)
+50 ;;=I73.9^^187^2438^22
+51 ;;^UTILITY(U,$J,358.3,49223,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,49223,1,3,0)
+54 ;;=3^Peripheral Vascular Disease,Unspec
+55 ;;^UTILITY(U,$J,358.3,49223,1,4,0)
+56 ;;=4^I73.9
+57 ;;^UTILITY(U,$J,358.3,49223,2)
+58 ;;=^184182
+59 ;;^UTILITY(U,$J,358.3,49224,0)
+60 ;;=I35.0^^187^2438^20
+61 ;;^UTILITY(U,$J,358.3,49224,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,49224,1,3,0)
+64 ;;=3^Nonrheumatic Aortic Vlve Stenosis
+65 ;;^UTILITY(U,$J,358.3,49224,1,4,0)
+66 ;;=4^I35.0
+67 ;;^UTILITY(U,$J,358.3,49224,2)
+68 ;;=^5007174
+69 ;;^UTILITY(U,$J,358.3,49225,0)
+70 ;;=I35.1^^187^2438^19
+71 ;;^UTILITY(U,$J,358.3,49225,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,49225,1,3,0)
+74 ;;=3^Nonrheumatic Aortic Vlve Insuff
+75 ;;^UTILITY(U,$J,358.3,49225,1,4,0)
+76 ;;=4^I35.1
+77 ;;^UTILITY(U,$J,358.3,49225,2)
+78 ;;=^5007175
+79 ;;^UTILITY(U,$J,358.3,49226,0)
+80 ;;=I35.2^^187^2438^21
+81 ;;^UTILITY(U,$J,358.3,49226,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,49226,1,3,0)
+84 ;;=3^Nonrheumatic Aortic Vlve Stenosis w/ Insuff
+85 ;;^UTILITY(U,$J,358.3,49226,1,4,0)
+86 ;;=4^I35.2
+87 ;;^UTILITY(U,$J,358.3,49226,2)
+88 ;;=^5007176
+89 ;;^UTILITY(U,$J,358.3,49227,0)
+90 ;;=I35.9^^187^2438^18
+91 ;;^UTILITY(U,$J,358.3,49227,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,49227,1,3,0)
+94 ;;=3^Nonrheumatic Aortic Vlve D/O,Unsp
+95 ;;^UTILITY(U,$J,358.3,49227,1,4,0)
+96 ;;=4^I35.9
+97 ;;^UTILITY(U,$J,358.3,49227,2)
+98 ;;=^5007178
+99 ;;^UTILITY(U,$J,358.3,49228,0)
+100 ;;=I42.7^^187^2438^3
+101 ;;^UTILITY(U,$J,358.3,49228,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,49228,1,3,0)
+104 ;;=3^Cardiomyopathy d/t Drug/Extrn Agent
+105 ;;^UTILITY(U,$J,358.3,49228,1,4,0)
+106 ;;=4^I42.7
+107 ;;^UTILITY(U,$J,358.3,49228,2)
+108 ;;=^5007198
+109 ;;^UTILITY(U,$J,358.3,49229,0)
+110 ;;=I21.3^^187^2438^23
+111 ;;^UTILITY(U,$J,358.3,49229,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,49229,1,3,0)
+114 ;;=3^STEMI,Unspec Site
+115 ;;^UTILITY(U,$J,358.3,49229,1,4,0)
+116 ;;=4^I21.3
+117 ;;^UTILITY(U,$J,358.3,49229,2)
+118 ;;=^5007087
+119 ;;^UTILITY(U,$J,358.3,49230,0)
+120 ;;=I25.5^^187^2438^17
+121 ;;^UTILITY(U,$J,358.3,49230,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,49230,1,3,0)
+124 ;;=3^Ischemic Cardiomyopathy
